| Variants of the BMP15 gene in a cohort of patients with premature ovarian failure. Tiotiu D., Alvaro Mercadal B., Imbert R., Verbist J., Demeestere I., De Leener A., Englert Y., Vassart G., Costagliola S., Delbaere A.
Hum. Reprod. 25:1581-1587(2010) · Mapped (1) |
| Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins. Sidis Y., Mukherjee A., Keutmann H., Delbaere A., Sadatsuki M., Schneyer A.
Endocrinology 147:3586-3597(2006) · Mapped (3) |
| Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism. Daelemans C., Smits G., de Maertelaer V., Costagliola S., Englert Y., Vassart G., Delbaere A.
J. Clin. Endocrinol. Metab. 89:6310-6315(2004) · Mapped (5) |
| A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome. Montanelli L., Delbaere A., Di Carlo C., Nappi C., Smits G., Vassart G., Costagliola S.
J. Clin. Endocrinol. Metab. 89:1255-1258(2004) · UniProtKB (1) |
| New insights into the pathophysiology of ovarian hyperstimulation syndrome. What makes the difference between spontaneous and iatrogenic syndrome? Delbaere A., Smits G., Olatunbosun O., Pierson R., Vassart G., Costagliola S.
Hum. Reprod. 19:486-489(2004) · Mapped (5) |
| Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. Smits G., Olatunbosun O., Delbaere A., Pierson R., Vassart G., Costagliola S.
N. Engl. J. Med. 349:760-766(2003) · UniProtKB (1) · Mapped (2) |
